Page last updated: 2024-10-30

ketotifen and Dermatitis, Exfoliative

ketotifen has been researched along with Dermatitis, Exfoliative in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Dermatitis, Exfoliative: The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder (e.g., atopic dermatitis, psoriasis, etc.), or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. (From Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Ketotifen treatment was very effective."1.29Diffuse erythrodermic cutaneous mastocytosis with bone marrow infiltration. ( Cevik, N; Irken, G; Olgun, N; Oren, B; Oren, H; Polat, M, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Olgun, N1
Oren, H1
Oren, B1
Irken, G1
Polat, M1
Cevik, N1

Other Studies

1 other study available for ketotifen and Dermatitis, Exfoliative

ArticleYear
Diffuse erythrodermic cutaneous mastocytosis with bone marrow infiltration.
    Dermatology (Basel, Switzerland), 1993, Volume: 187, Issue:2

    Topics: Biopsy; Bone Marrow; Bone Marrow Examination; Dermatitis, Exfoliative; Female; Humans; Infant; Ketot

1993